These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
438 related items for PubMed ID: 11734604
1. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. Agdeppa ED, Kepe V, Liu J, Flores-Torres S, Satyamurthy N, Petric A, Cole GM, Small GW, Huang SC, Barrio JR. J Neurosci; 2001 Dec 15; 21(24):RC189. PubMed ID: 11734604 [Abstract] [Full Text] [Related]
2. In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile. Agdeppa ED, Kepe V, Petri A, Satyamurthy N, Liu J, Huang SC, Small GW, Cole GM, Barrio JR. Neuroscience; 2003 Dec 15; 117(3):723-30. PubMed ID: 12617976 [Abstract] [Full Text] [Related]
3. 2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease. Agdeppa ED, Kepe V, Liu J, Small GW, Huang SC, Petric A, Satyamurthy N, Barrio JR. Mol Imaging Biol; 2003 Dec 15; 5(6):404-17. PubMed ID: 14667495 [Abstract] [Full Text] [Related]
5. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, Read S, Satyamurthy N, Petric A, Huang SC, Barrio JR. Am J Geriatr Psychiatry; 2002 Dec 15; 10(1):24-35. PubMed ID: 11790632 [Abstract] [Full Text] [Related]
6. Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies. Thompson PW, Ye L, Morgenstern JL, Sue L, Beach TG, Judd DJ, Shipley NJ, Libri V, Lockhart A. J Neurochem; 2009 Apr 15; 109(2):623-30. PubMed ID: 19226369 [Abstract] [Full Text] [Related]
7. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients. Kung MP, Skovronsky DM, Hou C, Zhuang ZP, Gur TL, Zhang B, Trojanowski JQ, Lee VM, Kung HF. J Mol Neurosci; 2003 Feb 15; 20(1):15-24. PubMed ID: 12663930 [Abstract] [Full Text] [Related]
8. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG. Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB. Neuroimage; 2010 Aug 15; 52(2):488-96. PubMed ID: 20385246 [Abstract] [Full Text] [Related]
9. The 2,6-disubstituted naphthalene derivative FDDNP labeling reliably predicts Congo red birefringence of protein deposits in brain sections of selected human neurodegenerative diseases. Smid LM, Vovko TD, Popovic M, Petric A, Kepe V, Barrio JR, Vidmar G, Bresjanac M. Brain Pathol; 2006 Apr 15; 16(2):124-30. PubMed ID: 16768752 [Abstract] [Full Text] [Related]
14. 99mTc- and Re-labeled 6-dialkylamino-2-naphthylethylidene derivatives as imaging probes for β-amyloid plaques. Cui M, Tang R, Li Z, Ren H, Liu B. Bioorg Med Chem Lett; 2011 Feb 01; 21(3):1064-8. PubMed ID: 21216146 [Abstract] [Full Text] [Related]
16. Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue. Ni R, Gillberg PG, Bergfors A, Marutle A, Nordberg A. Brain; 2013 Jul 01; 136(Pt 7):2217-27. PubMed ID: 23757761 [Abstract] [Full Text] [Related]
17. Synthesis and evaluation of 1-(4-[¹⁸F]fluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for β-amyloid plaque imaging. Lee I, Yang J, Lee JH, Choe YS. Bioorg Med Chem Lett; 2011 Oct 01; 21(19):5765-9. PubMed ID: 21885280 [Abstract] [Full Text] [Related]
18. Novel Benzothiazole Derivatives as Fluorescent Probes for Detection of β-Amyloid and α-Synuclein Aggregates. Watanabe H, Ono M, Ariyoshi T, Katayanagi R, Saji H. ACS Chem Neurosci; 2017 Aug 16; 8(8):1656-1662. PubMed ID: 28467708 [Abstract] [Full Text] [Related]